Showing results (1731-1740 of 3,513) with videos related to
Sort By:
Pageof 352
Toxicologic Pathology|September 19, 2001
Greater expression of transforming growth factor alpha and proliferating cell nuclear antigen staining in mouse hepatoblastomas than hepatocellular carcinomas induced by a diethylnitrosamine-sodium phenobarbital regimenT Sakairi, K Kobayashi, K Goto, et al.Toxicologic Pathology|August 22, 2002
Application of cDNA microarray technology to in vitro toxicology and the selection of genes for a real-time RT-PCR-based screen for oxidative stress in Hep-G2 cellsKevin T Morgan, Hong Ni, H Roger Brown, et al.Toxicologic Pathology|August 22, 2002
Endocardial myxomatous change in Harlan Sprague-Dawley rats (Hsd:S-D) and CD-1 mice: its microscopic resemblance to drug-induced valvulopathy in humansChandikumar S Elangbam, Karyn A Colman, Ruth M Lightfoot, et al.Toxicologic Pathology|August 22, 2002
"Have you seen this?" peliosis hepatisRichard Edwards, Tina Colombo, Peter GreavesToxicologic Pathology|June 15, 1999
Preclinical development strategies for novel gene therapeutic productsA M Pilaro, M A SerabianToxicologic Pathology|June 15, 1999
Safety assessment of biotechnology-derived pharmaceuticals: ICH and beyondM A Serabian, A M PilaroToxicologic Pathology|June 15, 1999
Development of a recombinant interleukin-4-Pseudomonas exotoxin for therapy of glioblastomaR K PuriToxicologic Pathology|June 15, 1999
BR96 sFv-PE40 immunotoxin: nonclinical safety assessmentH G Haggerty, W A Warner, C R Comereski, et al.Toxicologic Pathology|June 15, 1999
Correlation of toxicity and pharmacokinetic properties of a phosphorothioate oligonucleotide designed to inhibit ICAM-1S P Henry, M V Templin, N Gillett, et al.Toxicologic Pathology|June 15, 1999
Safety evaluation of human living skin equivalentsG M Nemecek, A D DayanPageof 352